These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38296726)

  • 21. Downregulation of lncRNA SNHG16 inhibits vascular smooth muscle cell proliferation and migration in cerebral atherosclerosis by targeting the miR-30c-5p/SDC2 axis.
    Yang SN; Zhong LY; Sun YH; Wang C; Ru WJ; Liu RZ; Dai W; Xie XM; Li SD
    Heart Vessels; 2022 Jun; 37(6):1085-1096. PubMed ID: 35320391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retraction notice to "MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1" [Biomed. Pharmacother. 102 (2018) 988-995].
    Li R; Dong B; Wang Z; Jiang T; Chen G
    Biomed Pharmacother; 2023 Aug; 164():114723. PubMed ID: 37088668
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of LncRNA SNHG16 on vascular smooth muscle cells in CHD by targeting miRNA-218-5p.
    Huang L; Ding Y; Yang L; Jiang X; Xia Z; You Z
    Exp Mol Pathol; 2021 Feb; 118():104595. PubMed ID: 33359036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum to "LncRNA SNHG16 reverses the effects of miR-15a/16 on LPS-induced inflammatory pathway" [Biomed. Pharmacother. 106 (2018) 1661-1667].
    Wang W; Lou C; Gao J; Zhang X; Du Y
    Biomed Pharmacother; 2021 Jan; 133():110894. PubMed ID: 33277114
    [No Abstract]   [Full Text] [Related]  

  • 25. Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2022 Jun; 150():112855. PubMed ID: 35341635
    [No Abstract]   [Full Text] [Related]  

  • 26. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 27. Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
    Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
    Biomed Pharmacother; 2023 Nov; 167():115375. PubMed ID: 37802728
    [No Abstract]   [Full Text] [Related]  

  • 28. Retraction notice to "miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer" [Biomed. Pharmacother. 95 (2017) 1718-1724].
    Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
    Biomed Pharmacother; 2024 Feb; 171():116187. PubMed ID: 38296728
    [No Abstract]   [Full Text] [Related]  

  • 29. SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1.
    Zhang K; Chen J; Song H; Chen LB
    Oncotarget; 2018 Jan; 9(1):1028-1040. PubMed ID: 29416674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retraction notice to "Inhibition of miR-31a-5p decreases inflammation by down-regulating IL-25 expression in human dermal fibroblast cells (CC-2511 cells) under hyperthermic stress via Wnt/β-catenin pathway" [Biomed. Pharmacother. 107 (2018) 24-33].
    Jiang L; Xue W; Wang Y
    Biomed Pharmacother; 2021 Oct; 142():112129. PubMed ID: 34507835
    [No Abstract]   [Full Text] [Related]  

  • 31. Retraction notice to "miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1" [Biomed. Pharmacother. 106 (2018) 1072-1081].
    Deng H; Geng Q; Ji T; Yang A
    Biomed Pharmacother; 2023 Jun; 162():114720. PubMed ID: 37087344
    [No Abstract]   [Full Text] [Related]  

  • 32. Retraction notice to "Effect of microRNA-129-5p targeting HMGB1-RAGE signaling pathway on revascularization in a collagenase-induced intracerebral hemorrhage rat model" [Biomed. Pharmacother. 93 (2017) 238-244].
    Ma XL; Li SY; Shang F
    Biomed Pharmacother; 2023 Nov; 167():115366. PubMed ID: 37802726
    [No Abstract]   [Full Text] [Related]  

  • 33. Retraction notice to "Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2" [Biomed. Pharmacother. 104 (2018) 705-711].
    Zhang L; Fang F; He X
    Biomed Pharmacother; 2023 Dec; 168():115377. PubMed ID: 37802724
    [No Abstract]   [Full Text] [Related]  

  • 34. Knockdown of lncRNA SNHG16 Attenuates the Proliferation and Radioresistance of Nasopharyngeal Carcinoma Cells by Mediating miR-31-5p/SFN Axis.
    Zhang W; Zhou X; Tang Z; Fu L; Zou S; Tang S
    Radiat Res; 2023 Feb; 199(2):124-131. PubMed ID: 36520963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].
    Xia H; Jing H; Li Y; Lv X
    Biomed Pharmacother; 2023 Dec; 169():115376. PubMed ID: 38016887
    [No Abstract]   [Full Text] [Related]  

  • 36. Overexpression of long non-coding RNA SNHG16 against cerebral ischemia-reperfusion injury through miR-106b-5p/LIMK1 axis.
    Pan H; Zhao F; Yang Y; Chang N
    Life Sci; 2020 Aug; 254():117778. PubMed ID: 32407850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retraction notice to "miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells" [Biomed. Pharmacother. 95 (2017) 120-128].
    Cai W; Jiang H; Yu Y; Xu Y; Zuo W; Wang S; Su Z
    Biomed Pharmacother; 2023 Apr; 160():114282. PubMed ID: 36725469
    [No Abstract]   [Full Text] [Related]  

  • 38. Retraction notice to "TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells" [Biomed. Pharmacother. 103 (2018) 1669-1677].
    Jiang N; Xia J; Jiang B; Xu Y; Li Y
    Biomed Pharmacother; 2022 Jun; 150():112856. PubMed ID: 35341638
    [No Abstract]   [Full Text] [Related]  

  • 39. Long non-coding RNA SNHG16 contributes to glioma malignancy by competitively binding miR-20a-5p with E2F1.
    Yang BY; Meng Q; Sun Y; Gao L; Yang JX
    J Biol Regul Homeost Agents; 2018; 32(2):251-261. PubMed ID: 29685003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction notice to "miR-149 regulates the proliferation and apoptosis of cervical canc er cells by targeting GIT1" [Biomed. Pharmacother. 105 (2018) 1106-1116].
    Qian B; Zhao L; Wang X; Xu J; Teng F; Gao L; Shen R
    Biomed Pharmacother; 2020 May; 125():109971. PubMed ID: 32070646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.